Genix Acquires 30 Ophthalmic Dossiers In Canada

Expects To Begin Commercialization From 2022

 
• By Dave Wallace

Canadian firm Genix has acquired 30 ophthalmic generic dossiers from Canagen. Genix expects to begin commercialization from 2022.

Canada
Genix has acquired 30 ophthalmic generics dossiers for the Canadian market • Source: Shutterstock

More from Deals

More from Business